trial is, in effect, a contract with FDA, and that violations of it are violations of FDA regulations and, hence, of federal law, and, ergo, are criminal offenses (Richardson, 1994). This view is disturbing from the perspective of an investigator, if for no other reason than that it seems apparent that given variation in patient needs there is no trial, regardless of how meticulously performed, capable of passing muster if it is subjected to sufficient retrospective scrutiny.
The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Ancillary Issues Raised During the Period Following The H3X-MC-PPPC Trial ."
Review of the Fialuridine (FIAU) Clinical Trials . Washington, DC: The National Academies Press,
Please select a format: